Investment Considerations Genprex is led by a seasoned management team boasting more than 50 years of combined industry experience. The company’s lead product candidate, REQORSA® (quaratusugene ozeplasmid), is being evaluated in multiple clinical trials as a treatment for non-small cell lung cancer and will soon be evaluated in a clinical trial for small cell lung … Continue reading “Genprex Inc. (NASDAQ: GNPX)”
Symbol | Release | Time | Source |
---|---|---|---|
{{ release.qmtopics.qmsymbol[0].symbol }} | {{ release.headline }} | {{ release.datetime | amDateFormat:'hh:mm A'}} | {{ release.source }} |
SmallCapRelations is part of the IBN (InvestorBrandNetwork).